Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 434

1.

Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.

Irwin DJ, Cohen TJ, Grossman M, Arnold SE, Xie SX, Lee VM, Trojanowski JQ.

Brain. 2012 Mar;135(Pt 3):807-18. doi: 10.1093/brain/aws013.

3.

18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.

Passamonti L, Vázquez Rodríguez P, Hong YT, Allinson KS, Williamson D, Borchert RJ, Sami S, Cope TE, Bevan-Jones WR, Jones PS, Arnold R, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB.

Brain. 2017 Mar 1;140(3):781-791. doi: 10.1093/brain/aww340.

5.

Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation.

Grinberg LT, Wang X, Wang C, Sohn PD, Theofilas P, Sidhu M, Arevalo JB, Heinsen H, Huang EJ, Rosen H, Miller BL, Gan L, Seeley WW.

Acta Neuropathol. 2013 Apr;125(4):581-93. doi: 10.1007/s00401-013-1080-2. Epub 2013 Jan 31.

6.

Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies.

Reynolds MR, Reyes JF, Fu Y, Bigio EH, Guillozet-Bongaarts AL, Berry RW, Binder LI.

J Neurosci. 2006 Oct 18;26(42):10636-45.

7.

Acetylated tau neuropathology in sporadic and hereditary tauopathies.

Irwin DJ, Cohen TJ, Grossman M, Arnold SE, McCarty-Wood E, Van Deerlin VM, Lee VM, Trojanowski JQ.

Am J Pathol. 2013 Aug;183(2):344-51. doi: 10.1016/j.ajpath.2013.04.025.

8.

Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies.

de Silva R, Lashley T, Gibb G, Hanger D, Hope A, Reid A, Bandopadhyay R, Utton M, Strand C, Jowett T, Khan N, Anderton B, Wood N, Holton J, Revesz T, Lees A.

Neuropathol Appl Neurobiol. 2003 Jun;29(3):288-302.

PMID:
12787326
9.

AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.

Vingtdeux V, Davies P, Dickson DW, Marambaud P.

Acta Neuropathol. 2011 Mar;121(3):337-49. doi: 10.1007/s00401-010-0759-x. Epub 2010 Oct 19.

10.
11.

Nitration of tau protein is linked to neurodegeneration in tauopathies.

Horiguchi T, Uryu K, Giasson BI, Ischiropoulos H, LightFoot R, Bellmann C, Richter-Landsberg C, Lee VM, Trojanowski JQ.

Am J Pathol. 2003 Sep;163(3):1021-31. Erratum in: Am J Pathol. 2003 Dec;163(6):2645.

12.

Argyrophilic grain disease is a sporadic 4-repeat tauopathy.

Togo T, Sahara N, Yen SH, Cookson N, Ishizawa T, Hutton M, de Silva R, Lees A, Dickson DW.

J Neuropathol Exp Neurol. 2002 Jun;61(6):547-56.

PMID:
12071638
13.

An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.

Carlomagno Y, Chung DC, Yue M, Castanedes-Casey M, Madden BJ, Dunmore J, Tong J, DeTure M, Dickson DW, Petrucelli L, Cook C.

J Biol Chem. 2017 Sep 15;292(37):15277-15286. doi: 10.1074/jbc.M117.794602. Epub 2017 Jul 31.

14.
15.

Tau phosphorylation and aggregation as a therapeutic target in tauopathies.

Badiola N, Suárez-Calvet M, Lleó A.

CNS Neurol Disord Drug Targets. 2010 Dec;9(6):727-40. Review.

PMID:
20942789
16.

The acetylation of tau inhibits its function and promotes pathological tau aggregation.

Cohen TJ, Guo JL, Hurtado DE, Kwong LK, Mills IP, Trojanowski JQ, Lee VM.

Nat Commun. 2011;2:252. doi: 10.1038/ncomms1255.

17.
18.

Mutations causing neurodegenerative tauopathies.

Goedert M, Jakes R.

Biochim Biophys Acta. 2005 Jan 3;1739(2-3):240-50. Review.

19.

Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.

Arai T, Ikeda K, Akiyama H, Tsuchiya K, Iritani S, Ishiguro K, Yagishita S, Oda T, Odawara T, Iseki E.

Acta Neuropathol. 2003 May;105(5):489-98. Epub 2003 Feb 8.

PMID:
12677450
20.

Supplemental Content

Support Center